Clinical Trial News & How To Help Us Show The World What Our Products Can Do!
Published on Jan 28, 2020
“Right away with Qualia Mind, I noticed an increase in my mental energy and focus.”
“As a small business owner, Qualia Mind has doubled my productivity. It’s a game-changer for my career!”
“Eternus is amazing. I actually WANT to be active again! It’s not a chore anymore.”
These are actual quotes from our customers about our products. We’re flooded with them on testimonial pages, in emails, on phone calls, and face-to-face at events where we get to meet our community.
Our unique approach to nutritional formulations is changing lives in ways that even surprise our customers. And we can’t blame them for being surprised.
Consumers have to search long and hard in the noisy health and wellness industry for products that actually deliver.
For this reason, many of our customers begin their health journeys with us having one foot planted in understandable skepticism. This may explain their enthusiasm in reporting how well our products work, in ways that are often noticeable after just a day or two of use.
For the health challenges we address, we know if we can just get people to try our products, the overwhelming majority report stellar results.
That’s why we bend over backwards to take away all financial risk in trying us out.
We offer a 100 Day Moneyback Guarantee on every product we make. That is an easy decision when refund requests are as infrequent as they are with our customers.
And yet, we know despite tons of positive customer reviews online, and zero financial risk in trying our products, there are still some people who just flat out refuse to try our formulas without a mountain of scientific evidence backing them up.
So we do that too. Our website is loaded with hundreds of research citations on our product ingredients, videos on our unique formulation methods, and deep-dives into the health issues we address, with content from the ND’s, MD’s, and PhD’s comprising our science and medical team.
Some funding for this final public round of investment will be used for a major international launch of a forthcoming sleep product mentioned in our last update. But we also intend to use funding from this round to maximize concrete evidence of our products’ efficacy in the near future.
We are pursuing double-blind clinical trials on our products themselves.
Even though we cite hundreds of clinical studies on the power of the individual ingredients within our formulas, we wouldn’t claim our products are “clinically studied” until we can fund clinical trials to show what the combined effect is of all those individual ingredients when taken together, as a carefully crafted synergistic formula.
We’re already underway in providing objective scientific evidence for our products, and the pilot study results are very exciting. Cambridge Brain Sciences offers highly comprehensive cognitive assessment testing which have been cited in over 300 academically published studies. The results of a pilot study on Qualia Mind using Cambridge Brain Sciences’ cognitive assessment tools showed significant gains across 6 separate testing verticals of cognitive performance, from concentration, to verbal short-term memory, to planning skills. As the study did not have a placebo control, we cannot conclusively state if Qualia Mind was the cause of the increased scores. (I’ll link to the study at the bottom of the update).
So in order to confirm the results of our Qualia Mind pilot study with even greater rigor, we are currently conducting a double-blind placebo controlled clinical study of Qualia Mind, which was funded by earlier Wefunder investments. Participant recruitment is scheduled to begin next month, with results anticipated in Q3 of this year!
Our next move will be to fund a double-blind clinical study on our human longevity product Eternus.
Before that, however, we are hard at work generating initial data on the efficacy of Eternus. We have started pilot tests with Eternus to determine the NAD+ (and related metabolite) levels in volunteers after adding Eternus into their supplementation (NAD+ levels decrease with age). We also began testing the effects of Eternus using a device called Agemeter®, which measures 12 functional biomarkers of aging including memory, hearing, reactions, agility, decision speed, and lung function. These early studies will help create a fuller picture of the ways Eternus can improve the aging process.
Positive results from double blind clinical studies on our products would be an absolute game changer. Can you imagine our growth potential within the 500 billion dollar nutraceutical industry if we can generate the following clinical evidence:
- That we make products which can significantly increase mental performance metrics across a wide swath of categories?
- That we make products which can significantly decrease the rate of human aging?
It would be headline news if a multi-billion dollar Big Pharma company achieved either of those results with a medication, let alone a crowdfunded nutraceutical startup that uses a pioneering formulation process unlike anything the old-guard health industry even offers.
Our growth potential following positive results from double-blind clinical studies, could be very large, and your funding at this stage of our growth could enable the type of international headlines reserved for the largest breakthroughs in the global science and health community.
We have several years of unprecedented customer feedback, with over 80% of our customers now choosing subscriptions to our products rather than a one time purchase. We have a formulation approach unlike anything in the wellness brand market. We have scores of the most credentialed doctors and nutritional experts on earth promoting and advocating for our brand. We’ve compiled so much research on the rare and potent ingredients in our formulas that our website is now commonly linked to by other health sites for the repository of research data on it.
All we lack, is the final piece; the expensive step of funding double blind clinicals, so we can prove once and for all that that the source of all this smoke, is a very real fire, and a very real breakthrough in how the complex adaptive system of the human body, can be brought into a harmony of self-regulation, so human beings en masse can experience the highest standard of wellness they have ever felt in their life.
Invest now and own a stake in turning the old-guard health industry on its head, and demonstrating- at the highest level of clinical rigor- what happens when a wellness startup cares more about causes of dysfunction than the symptoms of dysfunction.
Our 800+ co-owners in the Wefunder community are already part of making this happen. Join us, and co-own a movement spearheading a sea change in how human health can be addressed at the causal level, for unprecedented new standards in human wellbeing.
Thank you so much!
*https://neurohacker.com/qualia-mind-pilot-study